HIGHLIGHTS
- who: Fleur van der Sijde and colleagues from the United States The State University of New Jersey have published the research work: Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients, in the Journal: (JOURNAL)
- what: The authors evaluated the levels of circulating cytokine concentrations before and after one cycle of FOLFIRINOX, and assessed differences between patients with and without progressive disease at chemotherapy response evaluation CT scans. The authors focus on responders and non-responders to FOLFIRINOX.
- how: Data were analyzed using SPSS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.